Human Genome Sciences' P2P Acquisition

Human Genome Sciences raised a round of funding on July 17, 2012. Investors include GlaxoSmithKline.

Human Genome Sciences is a development stage company that was formed to develop and commercialize therapeutically enhanced proprietary biopharmaceuticals with the aim of offering significant reduction…

Articles about Human Genome Sciences' P2P Acquisition: